Sukrut Shah and Anacetrapib - Free people check

(1 - 11 from 11

)

Safety of Anacetrapib in Patients with or at High Risk for ...

www.nejm.org

by CP Cannon · · Cited by 774 — Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease. List of authors. Christopher P. Cannon, M.D.,; Sukrut Shah, ... › doi › full › nejmoa

Doctor Sukrut Shah - esc365.escardio.org

esc365.escardio.org

Sukrut Shah. 1 presentation share on : 1 presentation from this speaker A multi-regional, randomized evaluation of the lipid-modifying efficacy and tolerability of anacetrapib added to ongoing statin therapy in patients with hypercholesterolemia or low HDL-C Congress : ESC Congress

Biotech Values : Merck abstract Session APS Fami...

investorshub.advfn.com

ariadndndough : Merck abstract Session APS Familial Hypercholesterolemia and Other Lipid Disorders Randomized Evaluation of Anacetrapib...

Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to...

www.proquest.com

Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol. Christie M. Ballantyne, MDa,*, Sukrut Shah, PhDb, Uma Kher, MSb, John A. Hunter, MSb,.

Effects of anacetrapib on plasma lipids in specific patient subgroups...

www.sciencedirect.com

Uma Kher, Sukrut Shah, Tanya B. Ashraf, Christine McCrary Sisk, Hayes Dansky, and Yale Mitchel are employees of Merck & Co., Inc., and may own stock and/or hold stock options in the company. Christopher P. Cannon reports grants from Accumetrics, Arisaph, AstraZeneca, and ...

Design of the DEFINE trial: Determining the EFficacy and Tolerability...

www.sciencedirect.com

Sukrut Shah. Search for articles by this author Affiliations. Merck Research Laboratories, Rahway, NJ, RPh, PhD, Joseph Rubino. x. Joseph Rubino. Search for articles by this …

All web results to the name "Sukrut Shah"

Safety of Anacetrapib in Patients with or at High Risk IMET

www.imet2000-pal.org

Christopher P. Cannon, M.D., Sukrut Shah, Ph.D., R.Ph., Hayes M. Dansky, M.D., Michael Davidson, M.D., Eliot A. Brinton, M.D., Antonio M. Gotto, Jr., M.D., ... › page

Safety of Anacetrapib in Patients with or at Risk for Coronary Heart...

slideplayer.com

Safety of Anacetrapib in Patients with or at Risk for Coronary Heart Disease Christopher P. Cannon, MD, Sukrut Shah, PhD, RPh, Hayes M. Dansky, MD, Michael.